secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-07-19T23:59:59+00:00
Accession:  0001824293-24-000084
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio increases ATM offering capacity by up to $1.04M, excluding prior $0.96M sales
--------------------------------------------------------------------------------

- Increased maximum aggregate sales price of shares under ATM agreement with H.C. Wainwright to $1,038,886, excluding $961,272 already sold.
- ATM agreement originally dated May 20, 2024; prospectus supplement filed July 19, 2024.
- Shares to be issued are common stock, par value $0.0001 per share; legal opinion from Mintz, Levin filed as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000084/0001824293-24-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000084/val-20240719.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer